CES 2022 is full of wearable tech companies betting that consumers want to constantly monitor their health metrics, 24/7.
This is one of the reasons that competition in space of Smart Ring is heating-up. Movano introduced its flagship product – the Movano Ring – earlier this week in Las Vegas. What remains unclear is how much it will cost. While the price, which is expected to be announced later this year, is significantly lower than that of the Oura Ring, the new company could become an extremely attractive option for health enthusiasts who want to buy their first smart ring. The Oura ring costs almost $400 & requires a subscription ($6 per month) to use all of its features.
Customer need accurate, useful data
The Movano Ring tracks the health of users on a wide range of parameters, including sleep, heart rate, heart rate variability, activity, respiration, temperature & blood oxygen. The company says its product differs from other wearable health trackers because it helps users & their doctors – make sense of data. “It gives you an insight so that you can make links between the cause & effect,” says the company. Their marketing materials make the implicit promise that a Movano ring can improve a user’s quality of life by showing how a user’s choices affect their health along the way. For Ex, the device can presumably “tell you why you slept the way you did & that your resting heart rate is higher after a few glasses of wine.”
Industry analyst David PringMill says the smart ring market could be ready for a company like Movano to take a big plunge. The “smart ring pioneer” Motiv led the way & the competitor “Ōura did the scientific validation to prove that … the heart measured with a “smart ring” the frequency variability can be closely correlated with the measurements obtained from medical grade EKG.
Movano tries to manufacture serious sanitary ware
It’s one thing to measure biosignals & show the results in nice graphics. Its quite another is to create a medical grade device that is stylish enough for everyday wear & FDA approved. This is apparently what Movano is trying to do. CEO John Mastrototaro told The Verge his company aims to make products that agency designates as Class II devices, which would put them in the same regulatory category as wheelchairs & home pregnancy tests, according to the agency. He says features going forward will include non-invasive blood sugar monitoring & blood pressure monitoring.
PringMill points out that technology that shows the effect of consumer choices could force users to face uncomfortable truths about what foods are available & which they can enjoy. He point-out that up to 80% of foods sold in grocery stores contain refined sugar. This means that a continuous blood glucose monitor would show spike after a user has eaten, well, most foods that currently available. He asks, “Even with this health data, how many users will be able to resist all this temptation & change their lifestyle?”